@misc{https://doi.org/10.5281/zenodo.4633834,<br/><span class="tab"></span>
  doi = {10.5281/ZENODO.4633834},<br/><span class="tab"></span>
  url = {https://zenodo.org/record/4633834},<br/><span class="tab"></span>
  author = {Castellotti,<br/><span class="tab"></span> Barbara and Gellera,<br/><span class="tab"></span> Cinzia and Messina,<br/><span class="tab"></span> Giuseppe},<br/><span class="tab"></span>
  keywords = {Gabapentin,<br/><span class="tab"></span> KCNQ2,<br/><span class="tab"></span> developmental and epileptic encephalopathy,<br/><span class="tab"></span> epilepsy,<br/><span class="tab"></span> loss-of-function,<br/><span class="tab"></span> precision medicine},<br/><span class="tab"></span>
  title = {Dataset related to article "Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy"},<br/><span class="tab"></span>
  publisher = {Zenodo},<br/><span class="tab"></span>
  year = {2021},<br/><span class="tab"></span>
  copyright = {Restricted Access}
}